Evidence map›Paper›PMID 19002211›Full record

ArticleEuropean journal of human genetics : EJHG2009

Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.

Robert Lyle, Frédérique Béna, Sarantis Gagos, Corinne Gehrig, Gipsy Lopez, Albert Schinzel, James Lespinasse, Armand Bottani, Sophie Dahoun, Laurence Taine and 18 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 136 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 2 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 2 syntheses or guidelines pooled it, 325 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  10. Article
  11. Autoimmune Thyroid Disease in Patients with Down Syndrome-Review.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 6 countries.

Robert LyleDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland. Robert.Lyle@medisin.uio.no
Frédérique Béna
Sarantis Gagos
Corinne Gehrig
Gipsy Lopez
Albert Schinzel
James Lespinasse
Armand Bottani
Sophie Dahoun
Laurence Taine
Martine Doco-Fenzy
Pascale Cornillet-Lefèbvre
Anna Pelet
Stanislas Lyonnet
Annick Toutain
Laurence Colleaux
Jürgen Horst
Ingo Kennerknecht
Nobuaki Wakamatsu
Maria Descartes
Judy C Franklin
Lina Florentin-Arar
Sophia Kitsiou
Emilie Aït Yahya-Graison
Maher Costantine
Pierre-Marie Sinet
Jean M Delabar
Stylianos E Antonarakis
University Hospital of Geneva · CHUniversity of Geneva · CHDélégation Paris 7 · FRInstitut Necker Enfants Malades · FRUniversity of Alabama at Birmingham · USUniversity of Münster · DEAichi Developmental Disability Center · JPCentre Hospitalier Universitaire de Tours · FRCentre National de la Recherche Scientifique · FRChildren's Hospital Agia Sophia · GRHôpital Pellegrin · FRInserm · FRUniversité de Reims Champagne-Ardenne · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Down syndrome (DS) is one of the most frequent congenital birth defects, and the most common genetic cause of mental retardation. In most cases, DS results from the presence of an extra copy of chromosome 21. DS has a complex phenotype, and a major goal of DS research is to identify genotype-phenotype correlations. Cases of partial trisomy 21 and other HSA21 rearrangements associated with DS features could identify genomic regions associated with specific phenotypes. We have developed a BAC array spanning HSA21q and used array comparative genome hybridization (aCGH) to enable high-resolution mapping of pathogenic partial aneuploidies and unbalanced translocations involving HSA21. We report the identification and mapping of 30 pathogenic chromosomal aberrations of HSA21 consisting of 19 partial trisomies and 11 partial monosomies for different segments of HSA21. The breakpoints have been mapped to within approximately 85 kb. The majority of the breakpoints (26 of 30) for the partial aneuploidies map within a 10-Mb region. Our data argue against a single DS critical region. We identify susceptibility regions for 25 phenotypes for DS and 27 regions for monosomy 21. However, most of these regions are still broad, and more cases are needed to narrow down the phenotypic maps to a reasonable number of candidate genomic elements per phenotype.

Indexed as

Chromosome DeletionPhenotypeAbnormalities, MultipleChromosomes, Human, Pair 21Comparative Genomic HybridizationDown SyndromeGenotypeHumansTrisomy

Identifiers

PMID19002211
PMCPMC2986205
OpenAlexW2085790004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.